Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference12 articles.
1. Cornelissen J, Gratwohl A, Schlenk R, Sierra J, Bornhauser M, Juliusson G, et al. The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach. Nat Rev Clin Oncol. 2012;9:579–90.
2. Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–47.
3. Forman SJ, Rowe JM. The myth of the second remission of acute leukaemia in the adult. Blood. 2013;121:1077–82.
4. Gale R, Horovitz M, Rees JK, Gray RG, Oken M, Estey EY, et al. Chemotherapy versus transplantation for acute myelogenous leukemia in second remission. Leukemia. 1996;10:13–19.
5. Burnett AK, Goldstone A, Hills RK, Milligan D, Prentice A, Yin J, et al. Curability of patients with acute myeloid leukaemia who did not undergo transplantation in first remission. J Clin Oncol. 2013;31:1293–301.